Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - Priority Announcement - Gastroenterology

University of British Columbia

$40,000.00

Class I PI3-kinase in intestinal homeostasis

FY 2011-12

Summary
Inflammatory bowel diseases include Crohn's Disease (CD) and ulcerative colitis. It is characterized by chronic, relapsing and remitting, or progressive inflammation of the intestine. In CD, inflammation is transmural, which means it is found through all layers of the intestine and can lead to fibrosis in approximately one-third of patients. While we have made tremendous strides in dampening down inflammation in CD, the underlying cause(s) of disease remains unknown. Approximately 10 percent of IBD patients can not be treated by current therapies and we have had no impact on reducing the incidence of intestinal fibrosis in CD. New strategies to target intestinal inflammation and resulting complications are urgently needed. We have recently found that a protein known as SHIP, which is found in white blood cells, can block intestinal inflammation. There are 4 enzymes that SHIP regulates and which may cause intestinal inflammation so we are investigating the role that each of them plays in disease.
Program
Operating Grant - Priority Announcement - Gastroenterology
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
246665
Name
Sly Laura M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Abbott Laboratories (St-Laurent, Quebec); Canadian Association of Gastroenterology (Oakville, Ontario)
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Hematology, Digestive Disease & Kidney
Projecttitle
Class I PI3-kinase in intestinal homeostasis
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$40,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement - Gastroenterology
Keyworddelim
Animal Modeling; Cell Signaling; Crohn'S Disease; Inflammatory Bowel Disease; Intestinal Fibrosis; Intestinal Inflammation
Abstract
Inflammatory bowel diseases include Crohn's Disease (CD) and ulcerative colitis. It is characterized by chronic, relapsing and remitting, or progressive inflammation of the intestine. In CD, inflammation is transmural, which means it is found through all layers of the intestine and can lead to fibrosis in approximately one-third of patients. While we have made tremendous strides in dampening down inflammation in CD, the underlying cause(s) of disease remains unknown. Approximately 10 percent of IBD patients can not be treated by current therapies and we have had no impact on reducing the incidence of intestinal fibrosis in CD. New strategies to target intestinal inflammation and resulting complications are urgently needed. We have recently found that a protein known as SHIP, which is found in white blood cells, can block intestinal inflammation. There are 4 enzymes that SHIP regulates and which may cause intestinal inflammation so we are investigating the role that each of them plays in disease.
Competitiondate
201109
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sly, Laura M
Approvedterm
1 an 0 mois
Cihrcontribution2
Patient Oriented Research~ $40,000~ $0~